JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Net Income ScalingExpanding
Percentile Rank93
3Y CAGR+26.6%
5Y CAGR-1.3%
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

3Y CAGR
+26.6%/yr
vs -10.4%/yr prior
5Y CAGR
-1.3%/yr
Recent acceleration
Acceleration
+37.0pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$8.39B+988.7%
2024$771.00M+226.4%
2023$-610.00M-114.7%
2022$4.14B-50.5%
2021$8.36B-6.9%
2020$8.98B+56.4%
2019$5.74B-10.6%
2018$6.43B+11.7%
2017$5.76B+46.9%
2016$3.92B-